Predicting Antidepressant Treatment Response Using Functional Brain Controllability Analysis

Area of Science:

• Neuroscience
• Computational Psychiatry
• Biomarker Discovery

Background:

• Predicting antidepressant response remains a significant clinical challenge.
• Existing methods lack precision in identifying treatment responders early.
• Functional brain network controllability (fBNC) offers a novel approach to analyze brain dynamics.

Purpose of the Study:

• To investigate the utility of fBNC in predicting antidepressant treatment response in depression patients.
• To identify pretreatment brain network characteristics differentiating responders from nonresponders.
• To explore the potential of fBNC as a biomarker for personalized depression treatment.

Main Methods:

• Employed functional brain network controllability (fBNC) analysis on resting-state fMRI data.
• Analyzed pretreatment data from 20 unmedicated depression patients undergoing a 6-week escitalopram trial.
• Assessed treatment outcomes using Hamilton Depression Rating Scale (HAMD) scores.

Main Results:

• Treatment responders exhibited higher global average controllability and lower global modal controllability.
• Responders showed greater regional average controllability and smaller regional modal controllability within the default mode network.
• No significant differences in neuromodulation effects were found between responders and nonresponders.

Conclusions:

• fBNC measures serve as potential novel biomarkers for predicting antidepressant response in depression.
• Findings support the use of neuromodulation strategies for treating antidepressant nonresponders.
• Early identification of treatment response can personalize therapy, reduce suffering, and lower costs.